China’s First Cloned Kitten, Garlic

Owner Huang Yu dug up his deceased cat to give its cells to the pet-cloning company Sinogene.

| 3 min read
cat paw

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © ISTOCK, THEKORP

Businessman Huang Yu has become the proud pet parent of China’s first cloned cat.

Devastated by the death of his previous cat, Garlic, Huang sought the services of biotechnology company Sinogene. The Beijing-based firm charged Huang ¥250,000 (about $35,000 US) to generate a clone of his beloved pet, according to the Chinese news outlet The Global Times. The resulting kitten, also named Garlic, was born on July 21 and will stay at the Sinogene lab for another month before being sent home, according to The New York Times.

“In my heart, Garlic is irreplaceable. Garlic didn’t leave anything for future generations, so I could only choose to clone,” says Huang in an interview with The New York Times.

Sinogene has offered pet-cloning services since 2015 and has cloned 40 dogs so far, each at $53,000 a pop. The company began attempting to clone Garlic after seeing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development